Loading compound...
Small molecule research compound
Eli프로딜 (Eli프로딜) is a small molecule currently being studied for its potential to treat Parkinson's disease and other movement disorders. It is still in the research phase and has not been approved for general use.
How it worksEli프로딜 is being investigated for its ability to affect movement disorders, specifically targeting conditions like Parkinson's disease.
Used for
Parkinson's diseaseMovement disorders
Conditions
Parkinson diseaseMovement disorders
Class
Small moleculeResearch compoundSmall molecule research compoundNervous system
How to take
This drug is currently in clinical development (Phase 2) and is not yet available for prescription use by the general public.
Key warnings
- ·Research data indicates potential activity related to the HERG channel, which can affect heart rhythm.
Side effects
Serious
- ·Potential heart rhythm effects (based on HERG activity findings in research)
Seek help if
- ·Changes in heart rhythm
Talk to your doctor
Monitor
- ·Heart rhythm/cardiac health
Questions to ask
- ·What stage of clinical trials is Eli프로딜 in?
- ·Are there any known risks regarding heart rhythm with this compound?
Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.